Subscribe To
Roche's (rhhby) 2021 earnings, sales grow on covid-19 tests
Roche (RHHBY) performance in the fourth quarter and 2021 was encouraging, driven by demand for COVID-19...
February 3, 2022, 12:15 pm
Roche's (rhhby) 2021 earnings, sales grow on covid-19 tests
Roche (RHHBY) performance in the fourth quarter and 2021 was encouraging, driven by demand for COVID-19...
February 3, 2022, 12:15 pm
Roche's (rhhby) 2021 earnings, sales grow on covid-19 tests
Roche (RHHBY) performance in the fourth quarter and 2021 was encouraging, driven by demand for COVID-19...
February 3, 2022, 12:15 pm
Formfactor (form) q4 earnings beat, revenues increase y/y
FormFactor's (FORM) fourth-quarter 2021 earnings are driven by strong demand for DRAM, Flash and System...
February 3, 2022, 12:15 pm
Formfactor (form) q4 earnings beat, revenues increase y/y
FormFactor's (FORM) fourth-quarter 2021 earnings are driven by strong demand for DRAM, Flash and System...
February 3, 2022, 12:15 pm
Formfactor (form) q4 earnings beat, revenues increase y/y
FormFactor's (FORM) fourth-quarter 2021 earnings are driven by strong demand for DRAM, Flash and System...
February 3, 2022, 12:15 pm
Incyte (incy) to report q4 earnings: what's in the offing?
Jakafi sales are likely to have driven Incyte's (INCY) top-line in the fourth quarter....
February 3, 2022, 11:30 am
Incyte (incy) to report q4 earnings: what's in the offing?
Jakafi sales are likely to have driven Incyte's (INCY) top-line in the fourth quarter....
February 3, 2022, 11:30 am
Incyte (incy) to report q4 earnings: what's in the offing?
Jakafi sales are likely to have driven Incyte's (INCY) top-line in the fourth quarter....
February 3, 2022, 11:30 am
Cummins reports mixed q4 results; expects china demand to moderate in fy22
Cummins Inc. CMI reported fourth-quarter sales of $5.85 billion, flat year-over-year, beating the consensus of $5.79 billion. Sales in North America...
February 3, 2022, 9:19 am
Cummins reports mixed q4 results; expects china demand to moderate in fy22
Cummins Inc. CMI reported fourth-quarter sales of $5.85 billion, flat year-over-year, beating the consensus of $5.79 billion. Sales in North America...
February 3, 2022, 9:19 am
Cummins reports mixed q4 results; expects china demand to moderate in fy22
Cummins Inc. CMI reported fourth-quarter sales of $5.85 billion, flat year-over-year, beating the consensus of $5.79 billion. Sales in North America...
February 3, 2022, 9:19 am
Qorvo (qrvo) beats q3 earnings estimates on higher revenues
Qorvo (QRVO) beat fiscal third-quarter earnings estimates on healthy top-line growth driven by broad-ba...
February 3, 2022, 9:14 am
Qorvo (qrvo) beats q3 earnings estimates on higher revenues
Qorvo (QRVO) beat fiscal third-quarter earnings estimates on healthy top-line growth driven by broad-ba...
February 3, 2022, 9:14 am
Qorvo (qrvo) beats q3 earnings estimates on higher revenues
Qorvo (QRVO) beat fiscal third-quarter earnings estimates on healthy top-line growth driven by broad-ba...
February 3, 2022, 9:14 am
Earnings beat in the cards for news corp's stock?
News Corp, a global, diversified media and information services company, is scheduled to report its fiscal second-quarter results on Thursday, Februar...
February 3, 2022, 8:00 am
Earnings beat in the cards for news corp's stock?
News Corp, a global, diversified media and information services company, is scheduled to report its fiscal second-quarter results on Thursday, Februar...
February 3, 2022, 8:00 am
Earnings beat in the cards for news corp's stock?
News Corp, a global, diversified media and information services company, is scheduled to report its fiscal second-quarter results on Thursday, Februar...
February 3, 2022, 8:00 am
Erasca to present at the guggenheim healthcare talks 2022 oncology day
SAN DIEGO, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discoverin...
February 3, 2022, 8:00 am
Erasca to present at the guggenheim healthcare talks 2022 oncology day
SAN DIEGO, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discoverin...
February 3, 2022, 8:00 am